propofol has been researched along with Cancer of Liver in 36 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effects of propofol post-conditioning (PPC) on hepatic ischaemia/reperfusion injury (HIRI) and the potential mechanisms that might be involved in the interaction of Brahma-related gene1(BRG1) and Nuclear-related factor 2(Nrf2)." | 9.24 | Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice. ( Cai, J; Chen, C; Chen, H; Ge, M; Hei, Z; Jin, Y; Yao, W; Yuan, D; Zhu, Q, 2017) |
| "The Chinese and English medical databases were searched using a combination of the following search terms: "propofol", "liver cancer", "anesthesia surgery", and "ischemia reperfusion injury" in Chinese or English language, respectively." | 9.12 | A meta-analysis and systematic review of propofol on liver ischemia-reperfusion injury protection during hepatocellular carcinoma anesthesia surgery. ( Chen, C; Feng, C; Qian, D, 2021) |
| "To explore the protective effect and mechanism of ligustrazine (LGT) and propofol (PRO) on peri-operational liver ischemia-reperfusion injury (HIRI)." | 9.12 | [Protective effect of ligustrazine and propofol on peri-operational liver ischemia-reperfusion injury]. ( Hu, Z; Lin, LN; Wang, WT; Wu, JZ; Xie, K, 2006) |
| "To explore the protective effect of propofol on liver during hepatic ischemia/reperfusion injury (HIRI) and its mechanisms in patients undergoing liver surgery." | 9.11 | [Protective effect of propofol on liver during ischemia-reperfusion injury in patients undergoing liver surgery]. ( Hu, ZY; Lin, LN; Wang, WT; Wu, JZ; Xie, KJ, 2004) |
| " Among those patients, 135 patients underwent propofol anesthesia (propofol group), and 145 patients under sevoflurane combined anesthesia (sevoflurane group)." | 7.91 | Effect of propofol and sevoflurane anesthesia on postoperative cognitive function and levels of Aβ-42 and Tau in patients undergoing hepatectomy. ( Hou, JF; Xiao, CL, 2019) |
| "Propofol anaesthesia was associated with better survival in hepatocellular carcinoma patients who underwent hepatectomy." | 7.91 | Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study. ( Chan, SM; Huang, YH; Lai, HC; Lee, MS; Lin, C; Lin, KT; Wong, CS; Wu, ZF, 2019) |
| "Propofol is one of the most extensively used intravenous anaesthetic agents, which has been found to improve the surgical intervention outcome of several types of cancer, including hepatocellular carcinoma (HCC)." | 7.91 | Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/β-catenin signalling activation. ( Chen, X; Chen, Z; Deng, Z; Gong, T; Huang, S; Liu, M; Luo, R; Ning, X; Xu, Y; Zhou, B, 2019) |
| "We previously confirmed that propofol directly inhibited the viability, proliferation, and invasiveness of hepatocellular carcinoma cells in vitro." | 7.80 | Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells. ( Jin, HY; Jin, TT; Shan, WF; Wu, GQ; Xiong, XX; Zhang, J; Zhu, SM, 2014) |
| "Propofol decreases hepatocellular carcinoma cell invasiveness, which is partly due to the down-regulation of MMP-9 expression by miR-199a." | 7.79 | Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. ( Feng, ZY; Wu, GQ; Zhang, D; Zhang, J; Zhu, SM, 2013) |
| "The preparation and characterization of a novel escheriosomal nanoparticle formulation of a potent anticancer conjugate, 2,6-diisopropylphenol-linoleic acid (2,6P-LA), and evaluation of its anticancer efficacy against diethyl nitrosamine-induced hepatocellular carcinoma (HCC) in BALB/c mice." | 7.79 | Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma. ( Jabeen, M; Khan, AA; Owais, M, 2013) |
| "Propofol could inhibit cell proliferation, migration, and invasion and induce apoptosis via suppression on SHH to inactivate the SHH pathway." | 5.91 | Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway. ( Lai, S; Liu, Y; Wang, W; Wu, J; Wu, T; Yang, L; Zhou, F, 2023) |
| "However, liver cancer is mostly found at an advanced stage, is difficult to remove by surgery, and has a very high recurrence rate after surgery." | 5.62 | The effect of propofol on the proliferation and apoptosis of hepatocellular carcinoma cells through TGF-Β1/Smad2 signaling pathway. ( Li, Z; Liu, H; Tan, H; Zhang, Y, 2021) |
| "Propofol is an intravenous anesthetic extensively used in clinical." | 5.56 | Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5. ( Sun, H; Sun, Y, 2020) |
| "When propofol was used as the main general anesthetic agent for laparoscopic hepatic resection, the postoperative 2-year recurrence rate decreased in early- and intermediate-stage HCC." | 5.56 | Retrospective Comparison between the Effects of Propofol and Inhalation Anesthetics on Postoperative Recurrence of Early- and Intermediate-Stage Hepatocellular Carcinoma. ( Koo, BW; Lim, DJ; Na, HS; Oh, AY, 2020) |
| "Propofol is a commonly used drug for the induction and maintenance of anesthesia." | 5.56 | Propofol‑induced HOXA11‑AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‑4458. ( Feng, Y; Jin, Y; Liu, J; Song, F, 2020) |
| "Propofol treatment downregulated the protein levels of Vimentin, MMP-2, and MMP-9 while increasing that of E-cadherin." | 5.51 | Propofol inhibits proliferation, migration, and invasion of hepatocellular carcinoma cells by downregulating Twist. ( Fu, Y; Yang, T; Zheng, H, 2019) |
| "To explore the effects of propofol post-conditioning (PPC) on hepatic ischaemia/reperfusion injury (HIRI) and the potential mechanisms that might be involved in the interaction of Brahma-related gene1(BRG1) and Nuclear-related factor 2(Nrf2)." | 5.24 | Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice. ( Cai, J; Chen, C; Chen, H; Ge, M; Hei, Z; Jin, Y; Yao, W; Yuan, D; Zhu, Q, 2017) |
| "The Chinese and English medical databases were searched using a combination of the following search terms: "propofol", "liver cancer", "anesthesia surgery", and "ischemia reperfusion injury" in Chinese or English language, respectively." | 5.12 | A meta-analysis and systematic review of propofol on liver ischemia-reperfusion injury protection during hepatocellular carcinoma anesthesia surgery. ( Chen, C; Feng, C; Qian, D, 2021) |
| "To explore the protective effect and mechanism of ligustrazine (LGT) and propofol (PRO) on peri-operational liver ischemia-reperfusion injury (HIRI)." | 5.12 | [Protective effect of ligustrazine and propofol on peri-operational liver ischemia-reperfusion injury]. ( Hu, Z; Lin, LN; Wang, WT; Wu, JZ; Xie, K, 2006) |
| "To explore the protective effect of propofol on liver during hepatic ischemia/reperfusion injury (HIRI) and its mechanisms in patients undergoing liver surgery." | 5.11 | [Protective effect of propofol on liver during ischemia-reperfusion injury in patients undergoing liver surgery]. ( Hu, ZY; Lin, LN; Wang, WT; Wu, JZ; Xie, KJ, 2004) |
| "Propofol has been previously demonstrated to relieve hepatocellular carcinoma (HCC)." | 4.02 | Propofol Ameliorates the Proliferation and Epithelial-Mesenchymal Transition of Hepatoma Carcinoma Cells via Non-Coding RNA Activated by DNA Damage (NORAD)/microRNA (miR)-556-3p/Migration and Invasion Enhancer 1 (MIEN1) Axis. ( Guan, E; Li, H; Liu, Y; Luo, K; Wang, X, 2021) |
| "Compared to propofol and general anesthesia, midazolam/fentanyl sedation was associated with an increased periprocedural perception of pain and lower local tumor progression-free survival." | 3.91 | Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts. ( de Jong, MC; de Vries, JJJ; Geboers, B; Gerçek, CC; Hoedemaker-Boon, CJ; Meijerink, MR; Nieuwenhuizen, S; Puijk, RS; Ruarus, AH; Scheffer, HJ; Thöne-Passchier, DH; van den Tol, PMP; Vroomen, LGPH; Ziedses des Plantes, V, 2019) |
| "Propofol anaesthesia was associated with better survival in hepatocellular carcinoma patients who underwent hepatectomy." | 3.91 | Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study. ( Chan, SM; Huang, YH; Lai, HC; Lee, MS; Lin, C; Lin, KT; Wong, CS; Wu, ZF, 2019) |
| "Propofol is one of the most extensively used intravenous anaesthetic agents, which has been found to improve the surgical intervention outcome of several types of cancer, including hepatocellular carcinoma (HCC)." | 3.91 | Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/β-catenin signalling activation. ( Chen, X; Chen, Z; Deng, Z; Gong, T; Huang, S; Liu, M; Luo, R; Ning, X; Xu, Y; Zhou, B, 2019) |
| " Among those patients, 135 patients underwent propofol anesthesia (propofol group), and 145 patients under sevoflurane combined anesthesia (sevoflurane group)." | 3.91 | Effect of propofol and sevoflurane anesthesia on postoperative cognitive function and levels of Aβ-42 and Tau in patients undergoing hepatectomy. ( Hou, JF; Xiao, CL, 2019) |
| "We previously confirmed that propofol directly inhibited the viability, proliferation, and invasiveness of hepatocellular carcinoma cells in vitro." | 3.80 | Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells. ( Jin, HY; Jin, TT; Shan, WF; Wu, GQ; Xiong, XX; Zhang, J; Zhu, SM, 2014) |
| "Propofol decreases hepatocellular carcinoma cell invasiveness, which is partly due to the down-regulation of MMP-9 expression by miR-199a." | 3.79 | Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. ( Feng, ZY; Wu, GQ; Zhang, D; Zhang, J; Zhu, SM, 2013) |
| "The preparation and characterization of a novel escheriosomal nanoparticle formulation of a potent anticancer conjugate, 2,6-diisopropylphenol-linoleic acid (2,6P-LA), and evaluation of its anticancer efficacy against diethyl nitrosamine-induced hepatocellular carcinoma (HCC) in BALB/c mice." | 3.79 | Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma. ( Jabeen, M; Khan, AA; Owais, M, 2013) |
| "For patients with liver cancer, monitoring the depth of anesthesia with Narcotrend on microwave coagulation can contribute to lower dosage of propofol and shorten duration of recovery during total intravenous anesthesia with propofol and fentanyl." | 2.75 | [Application of a narcotrend-assisted anesthesia in-depth monitor in the microwave coagulation for liver cancer during total intravenous anesthesia with propofol and fentanyl]. ( Huang, W; Lai, JL; Lai, RC; Lu, YL; Wang, XD; Xie, JD; Xu, MX, 2010) |
| "Propofol could inhibit cell proliferation, migration, and invasion and induce apoptosis via suppression on SHH to inactivate the SHH pathway." | 1.91 | Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway. ( Lai, S; Liu, Y; Wang, W; Wu, J; Wu, T; Yang, L; Zhou, F, 2023) |
| "50 samples of liver cancer and para-cancer tissues in patients were collected and the difference in the expression of miR-195-5p was then analyzed." | 1.72 | Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p. ( Gao, L; Zhang, X, 2022) |
| "However, liver cancer is mostly found at an advanced stage, is difficult to remove by surgery, and has a very high recurrence rate after surgery." | 1.62 | The effect of propofol on the proliferation and apoptosis of hepatocellular carcinoma cells through TGF-Β1/Smad2 signaling pathway. ( Li, Z; Liu, H; Tan, H; Zhang, Y, 2021) |
| "The apoptosis and metastasis were measured by flow cytometry and transwell assays." | 1.56 | Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis. ( Ai, Y; He, J; Liu, J; Wang, D; Xing, N; Yang, J; Yang, T; Zhao, H, 2020) |
| "Propofol is a commonly used drug for the induction and maintenance of anesthesia." | 1.56 | Propofol‑induced HOXA11‑AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‑4458. ( Feng, Y; Jin, Y; Liu, J; Song, F, 2020) |
| " Further analysis showed that intraoperative propofol dosage was correlated with ALT, AST, and miR-148a-3p after hepatectomy." | 1.56 | Diagnostic Value of Peripheral Blood miR-148a-3p in Patients with Liver Injury After Hepatectomy Under General Anesthesia with Propofol. ( Chen, Y; Duan, J, 2020) |
| "When propofol was used as the main general anesthetic agent for laparoscopic hepatic resection, the postoperative 2-year recurrence rate decreased in early- and intermediate-stage HCC." | 1.56 | Retrospective Comparison between the Effects of Propofol and Inhalation Anesthetics on Postoperative Recurrence of Early- and Intermediate-Stage Hepatocellular Carcinoma. ( Koo, BW; Lim, DJ; Na, HS; Oh, AY, 2020) |
| "Propofol is an intravenous anesthetic extensively used in clinical." | 1.56 | Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5. ( Sun, H; Sun, Y, 2020) |
| "Propofol treatment downregulated the protein levels of Vimentin, MMP-2, and MMP-9 while increasing that of E-cadherin." | 1.51 | Propofol inhibits proliferation, migration, and invasion of hepatocellular carcinoma cells by downregulating Twist. ( Fu, Y; Yang, T; Zheng, H, 2019) |
| "Propofol is a commonly used anaesthetic with controversial effects on cancer cells." | 1.48 | Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating miR-374a in Hepatocarcinoma Cell Lines. ( Hu, ZH; Li, Y; Li, ZW; Liu, SQ; Liu, Z; Zhang, JL, 2018) |
| "Propofol seems to be a promising drug in treating the terminal agitated state that can be associated with the dying process." | 1.29 | Propofol in terminal care. ( De Conno, F; Mercadante, S; Ripamonti, C, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (8.33) | 18.2507 |
| 2000's | 4 (11.11) | 29.6817 |
| 2010's | 16 (44.44) | 24.3611 |
| 2020's | 13 (36.11) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L | 1 |
| Zhang, X | 1 |
| Liu, Y | 3 |
| Wang, X | 1 |
| Li, H | 1 |
| Guan, E | 1 |
| Luo, K | 1 |
| Wu, J | 2 |
| Zhou, F | 2 |
| Lai, S | 2 |
| Wang, W | 2 |
| Wu, T | 2 |
| Yang, L | 2 |
| Sun, Y | 1 |
| Sun, H | 1 |
| Qi, J | 1 |
| Wu, Q | 1 |
| Zhu, X | 1 |
| Zhang, S | 1 |
| Chen, X | 2 |
| Chen, W | 1 |
| Sun, Z | 1 |
| Zhu, M | 1 |
| Miao, C | 1 |
| Koo, BW | 1 |
| Lim, DJ | 1 |
| Oh, AY | 1 |
| Na, HS | 1 |
| Chen, Y | 1 |
| Duan, J | 1 |
| Fei, G | 2 |
| Cao, M | 2 |
| Ge, C | 2 |
| Cui, L | 1 |
| Song, F | 1 |
| Liu, J | 2 |
| Feng, Y | 1 |
| Jin, Y | 2 |
| Wang, D | 1 |
| Xing, N | 1 |
| Yang, T | 2 |
| Zhao, H | 1 |
| He, J | 1 |
| Ai, Y | 1 |
| Yang, J | 1 |
| Xie, Y | 1 |
| Feng, C | 1 |
| Qian, D | 1 |
| Chen, C | 2 |
| Li, Z | 1 |
| Liu, H | 1 |
| Zhang, Y | 1 |
| Tan, H | 1 |
| Li, J | 1 |
| Liu, M | 2 |
| Zeng, B | 1 |
| Wang, Z | 1 |
| Ge, M | 1 |
| Chen, H | 1 |
| Zhu, Q | 1 |
| Cai, J | 1 |
| Yuan, D | 1 |
| Yao, W | 1 |
| Hei, Z | 1 |
| Liu, SQ | 1 |
| Zhang, JL | 1 |
| Li, ZW | 1 |
| Hu, ZH | 1 |
| Liu, Z | 1 |
| Li, Y | 2 |
| Hou, JF | 1 |
| Xiao, CL | 1 |
| Zheng, H | 1 |
| Fu, Y | 1 |
| Gong, T | 1 |
| Ning, X | 1 |
| Deng, Z | 1 |
| Zhou, B | 1 |
| Huang, S | 1 |
| Xu, Y | 1 |
| Chen, Z | 1 |
| Luo, R | 1 |
| Lai, HC | 1 |
| Lee, MS | 1 |
| Lin, C | 1 |
| Lin, KT | 1 |
| Huang, YH | 1 |
| Wong, CS | 1 |
| Chan, SM | 1 |
| Wu, ZF | 1 |
| Puijk, RS | 1 |
| Ziedses des Plantes, V | 1 |
| Nieuwenhuizen, S | 1 |
| Ruarus, AH | 1 |
| Vroomen, LGPH | 1 |
| de Jong, MC | 1 |
| Geboers, B | 1 |
| Hoedemaker-Boon, CJ | 1 |
| Thöne-Passchier, DH | 1 |
| Gerçek, CC | 1 |
| de Vries, JJJ | 1 |
| van den Tol, PMP | 1 |
| Scheffer, HJ | 1 |
| Meijerink, MR | 1 |
| Zhang, J | 2 |
| Zhang, D | 1 |
| Wu, GQ | 2 |
| Feng, ZY | 1 |
| Zhu, SM | 2 |
| Yang, LL | 1 |
| Ji, JS | 1 |
| Wu, W | 1 |
| Lei, LP | 1 |
| Zhao, ZW | 1 |
| Shao, GL | 1 |
| Zheng, JP | 1 |
| Shan, WF | 1 |
| Jin, TT | 1 |
| Xiong, XX | 1 |
| Jin, HY | 1 |
| Lu, L | 1 |
| Zhou, J | 1 |
| Shi, J | 1 |
| Peng, XJ | 1 |
| Qi, XX | 1 |
| Wang, Y | 1 |
| Li, FY | 1 |
| Zhou, FY | 1 |
| Liu, L | 1 |
| Liu, ZQ | 1 |
| Joung, KW | 1 |
| Choi, SS | 1 |
| Jang, DM | 1 |
| Kong, YG | 1 |
| Lee, HM | 1 |
| Shim, JH | 1 |
| Won, HJ | 1 |
| Shin, YM | 1 |
| Kim, PN | 1 |
| Song, MH | 1 |
| Lai, RC | 1 |
| Lu, YL | 1 |
| Huang, W | 2 |
| Xu, MX | 2 |
| Lai, JL | 1 |
| Xie, JD | 1 |
| Wang, XD | 1 |
| Cheung Ning, M | 1 |
| Karmakar, MK | 1 |
| Khan, AA | 2 |
| Jabeen, M | 1 |
| Owais, M | 1 |
| Lin, LN | 2 |
| Wang, WT | 2 |
| Wu, JZ | 2 |
| Hu, ZY | 1 |
| Xie, KJ | 1 |
| Hu, Z | 1 |
| Xie, K | 1 |
| Long, YH | 1 |
| Li, W | 1 |
| Wang, J | 1 |
| Chen, MS | 1 |
| Figiel, M | 1 |
| Allritz, C | 1 |
| Lehmann, C | 1 |
| Engele, J | 1 |
| Bichel, T | 1 |
| Joris, J | 1 |
| Jacquet, N | 1 |
| Lamy, M | 1 |
| Mercadante, S | 1 |
| De Conno, F | 1 |
| Ripamonti, C | 1 |
| Konstantinidou, AS | 1 |
| Balamoutsos, NG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Erector Spina Plain (ESP) Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation[NCT05009550] | 30 participants (Anticipated) | Interventional | 2021-05-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for propofol and Cancer of Liver
| Article | Year |
|---|---|
A meta-analysis and systematic review of propofol on liver ischemia-reperfusion injury protection during hepatocellular carcinoma anesthesia surgery.
Topics: Anesthesia; Carcinoma, Hepatocellular; China; Humans; Liver; Liver Neoplasms; Propofol; Reperfusion | 2021 |
Total intravenous anesthesia in South-African genetic porphyria (variegate porphyria).
Topics: Adult; Anesthesia, General; Anesthesia, Intravenous; Female; Humans; Liver Neoplasms; Porphyrias, He | 1993 |
7 trials available for propofol and Cancer of Liver
| Article | Year |
|---|---|
Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.
Topics: Adolescent; Adult; Aged; Animals; Antioxidants; Cell Line; DNA Helicases; Drug Repositioning; Female | 2017 |
[Clinical observation of remifentanyl and propofol injection in total intravenous anesthesia for percutaneous radiofrequency ablation].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Catheter Ablation; Female; Humans; Liver N | 2013 |
Comparative Effects of Dexmedetomidine and Propofol on US-Guided Radiofrequency Ablation of Hepatic Neoplasm Under Monitored Anesthesia Care: A Randomized Controlled Study.
Topics: Analgesics; Catheter Ablation; Dexmedetomidine; Female; Hemodynamics; Humans; Liver Neoplasms; Male; | 2015 |
[Application of a narcotrend-assisted anesthesia in-depth monitor in the microwave coagulation for liver cancer during total intravenous anesthesia with propofol and fentanyl].
Topics: Adult; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Electrocoagulation; Fentanyl; Hemody | 2010 |
[Protective effect of propofol on liver during ischemia-reperfusion injury in patients undergoing liver surgery].
Topics: Adult; Carboxypeptidases; Female; Free Radical Scavengers; Humans; Lipid Peroxides; Liver; Liver Neo | 2004 |
[Protective effect of ligustrazine and propofol on peri-operational liver ischemia-reperfusion injury].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Drug Therapy, Combination; Female; Humans; Lipid Peroxides; Liv | 2006 |
[Application of total intravenous anesthesia with remifentanyl and propofol to radiofrequency ablation].
Topics: Anesthesia Recovery Period; Anesthetics, Intravenous; Blood Pressure; Carbon Dioxide; Carcinoma, Hep | 2007 |
27 other studies available for propofol and Cancer of Liver
| Article | Year |
|---|---|
Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p.
Topics: Cell Death; Cell Line, Tumor; Cisplatin; Gene Expression Regulation, Neoplastic; Humans; Liver Neopl | 2022 |
Propofol Ameliorates the Proliferation and Epithelial-Mesenchymal Transition of Hepatoma Carcinoma Cells via Non-Coding RNA Activated by DNA Damage (NORAD)/microRNA (miR)-556-3p/Migration and Invasion Enhancer 1 (MIEN1) Axis.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; DNA Damage; Epithelial-Mesench | 2021 |
Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Hedgehog Proteins; Humans; Liver Ne | 2023 |
Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Hedgehog Proteins; Humans; Liver Ne | 2023 |
Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Hedgehog Proteins; Humans; Liver Ne | 2023 |
Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Hedgehog Proteins; Humans; Liver Ne | 2023 |
Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expr | 2020 |
Propofol attenuates the adhesion of tumor and endothelial cells through inhibiting glycolysis in human umbilical vein endothelial cells.
Topics: Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carcinoma, Hepatocellular; Cell Adhesion; Cell A | 2019 |
Retrospective Comparison between the Effects of Propofol and Inhalation Anesthetics on Postoperative Recurrence of Early- and Intermediate-Stage Hepatocellular Carcinoma.
Topics: Aged; Anesthetics; Anesthetics, Inhalation; Anesthetics, Intravenous; Carcinoma, Hepatocellular; Fem | 2020 |
Diagnostic Value of Peripheral Blood miR-148a-3p in Patients with Liver Injury After Hepatectomy Under General Anesthesia with Propofol.
Topics: Adult; Aged; Anesthesia, General; Anesthetics, Intravenous; Biomarkers; Female; Hepatectomy; Humans; | 2020 |
Propofol suppresses hepatocellular carcinoma by inhibiting NET1 through downregulating ERK/VEGF signaling pathway.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Down-Regulation; Drug Screening Assays, | 2020 |
Propofol‑induced HOXA11‑AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‑4458.
Topics: Anesthetics, Intravenous; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Prol | 2020 |
Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cocu | 2020 |
Different anaesthesia methods affect the development of hepatoblastoma after platelet activation.
Topics: Animals; Hepatoblastoma; Hypnotics and Sedatives; Liver Neoplasms; Pentobarbital; Platelet Activatio | 2021 |
The effect of propofol on the proliferation and apoptosis of hepatocellular carcinoma cells through TGF-Β1/Smad2 signaling pathway.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Female; Hep G2 Cells; Humans; Liv | 2021 |
Propofol induces hepatocellular carcinoma cell apoptosis via regulating miR-105/JAK2/STAT3 axis.
Topics: Apoptosis; Base Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, N | 2021 |
Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating miR-374a in Hepatocarcinoma Cell Lines.
Topics: 3' Untranslated Regions; Antagomirs; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Movement; | 2018 |
Effect of propofol and sevoflurane anesthesia on postoperative cognitive function and levels of Aβ-42 and Tau in patients undergoing hepatectomy.
Topics: Adult; Amyloid beta-Peptides; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Carcino | 2019 |
Propofol inhibits proliferation, migration, and invasion of hepatocellular carcinoma cells by downregulating Twist.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relati | 2019 |
Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/β-catenin signalling activation.
Topics: Anesthetics, Intravenous; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell | 2019 |
Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study.
Topics: Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenous; Carcinoma, Hepatocellula | 2019 |
Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts.
Topics: Ablation Techniques; Aged; Anesthesia, General; Cohort Studies; Female; Humans; Hypnotics and Sedati | 2019 |
Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression.
Topics: Anesthetics, Intravenous; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Dose-Response Rel | 2013 |
Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carcinoma, Hepatocellular; Cell Line, Tumor; C | 2014 |
Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
Topics: Adult; Camptothecin; Carcinoma, Hepatocellular; Genistein; Glucuronosyltransferase; Humans; Inactiva | 2015 |
Right thoracic paravertebral anaesthesia for percutaneous radiofrequency ablation of liver tumours.
Topics: Adult; Aged; Analgesics; Catheter Ablation; Female; Fentanyl; Fluoroscopy; Humans; Infusions, Intrav | 2011 |
Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; DNA Fragmentation; Humans; Linoleic Acid; | 2013 |
Gap junctional control of glial glutamate transporter expression.
Topics: Animals; Anticonvulsants; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Connexin 43; | 2007 |
Propofol in terminal care.
Topics: Delirium; Humans; Hypnotics and Sedatives; Liver Neoplasms; Male; Middle Aged; Myoclonus; Palliative | 1995 |
Paraplegia in a patient who by chance missed the insertion of an epidural catheter.
Topics: Anesthesia, Epidural; Anesthesia, Intravenous; Anesthetics, Intravenous; Antineoplastic Combined Che | 1996 |